Avoro Capital Advisors LLC Portfolio Holdings

Avoro Capital Advisors LLC

  • $7.32 Billion
  • Q3 2025

Avoro Capital Advisors LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $7.32 Billion distributed in 32 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.02B, United Therapeutics Corp with a value of $848M, Madrigal Pharmaceuticals, Inc. with a value of $841M, Argenx Se with a value of $730M, and Krystal Biotech, Inc. with a value of $490M.

Examining the 13F form we can see an increase of $1.83B in the current position value, from $5.48B to 7.32B.

Avoro Capital Advisors LLC is based out at New York, NY

Below you can find more details about Avoro Capital Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $7.32 Billion
Healthcare: $7.32 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.4B
$1.02 Billion 13.88% of portfolio
5,110,000
Q3 2025 Added 2.61%
$21.2B
$848 Million 11.58% of portfolio
2,022,222
Q3 2025 Reduced 14.67%
$9.05B
$841 Million 11.49% of portfolio
1,833,000
Q3 2025 Reduced 2.24%
$50.2B
$730 Million 9.98% of portfolio
990,000
Q3 2025 Reduced 15.74%
$5.29B
$490 Million 6.7% of portfolio
2,777,777
Q3 2025 Added 4.43%
$4.37B
$376 Million 5.14% of portfolio
10,900,000
Q3 2025 Added 2.83%
$3.55B
$359 Million 4.91% of portfolio
6,350,000
Q3 2025 Reduced 3.14%
$4.4B
$334 Million 4.56% of portfolio
3,542,500
Q3 2025 Added 12.26%
$3.69B
$333 Million 4.55% of portfolio
7,645,000
Q3 2025 Added 8.44%
$2.23B
$277 Million 3.78% of portfolio
12,222,222
Q4 2024 Added 10.0%
$2.6B
$262 Million 3.58% of portfolio
10,808,080
Q3 2025 Added 116.16%
$1.4B
$259 Million 3.54% of portfolio
4,444,444
Q3 2025 Added 22.61%
$2.54B
$217 Million 2.96% of portfolio
5,400,000
Q2 2025 Reduced 5.95%
$2.52B
$188 Million 2.57% of portfolio
3,955,555
Q3 2025 Added 13.02%
$766M
$180 Million 2.46% of portfolio
6,210,000
Q3 2025 Reduced 1.43%
$875M
$120 Million 1.64% of portfolio
10,250,000
Q3 2025 Added 38.51%
$690M
$93.8 Million 1.28% of portfolio
6,387,790
Q3 2025 Reduced 5.37%
$204M
$68.4 Million 0.93% of portfolio
21,700,000
Q2 2025 Added 8.5%
$4.77B
$67.2 Million 0.92% of portfolio
2,240,000
Q3 2025 Reduced 22.76%
$1.3B
$24 Million 0.33% of portfolio
4,468,877
Q3 2025 Reduced 23.61%
$472M
$14.3 Million 0.2% of portfolio
2,000,000
Q3 2025 Reduced 51.81%
$1.32B
$9.49 Million 0.13% of portfolio
1,250,000
Q3 2025 Reduced 72.22%
$35.9M
$4.87 Million 0.07% of portfolio
2,849,402
Q3 2022 Added 55.76%
$720M
$4.58 Million 0.06% of portfolio
545,000
Q3 2025 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 5.38%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 25.75%
Septerna Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 8.08%
Oruka Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Structure Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 32
  • Current Value $7.32 Billion
  • Prior Value $5.48 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 3 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email